CD8A and rheumatoid arthritis: Furthermore, KLRK1 (NKG2D) was a C-type lectin receptor present on natural killer (NK) cells, γδ, CD8+ and CD4+ T cells, and its gene polymorphisms might modify the risk of development and severity of RA (66).